US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Regional Analysis

6.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue 2020-2030 (US$ Million)

6.3 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Forecast Analysis

7. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Analysis – by Product

7.1 Instruments

7.1.1 Overview
7.1.2 Instruments: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Consumables

7.2.1 Overview
7.2.2 Consumables: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Accessories

7.3.1 Overview
7.3.2 Accessories: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.4 Software

7.4.1 Overview
7.4.2 Software: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Analysis – by Application

8.1 Cancer Diagnosis

8.1.1 Overview
8.1.2 Cancer Diagnosis: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Genetic Disease Diagnosis

8.2.1 Overview
8.2.2 Genetic Disease Diagnosis: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Infectious Disease Diagnostic

8.3.1 Overview
8.3.2 Infectious Disease Diagnostic: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Analysis – by End User

9.1 Diagnostic Laboratories

9.1.1 Overview
9.1.2 Diagnostic Laboratories: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Contract Research Organizations

9.2.1 Overview
9.2.2 Contract Research Organizations: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Pharmaceutical and Biotechnological Companies

9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnological Companies: US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – United States Analysis

10.1 Overview

10.2 United States

10.2.1 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Breakdown, by Key Country, 2023 and 2030 (%)
10.2.1.1 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast Analysis – by Country
10.2.1.1 United States : US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.1.1 United States : US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Breakdown, by Product
10.2.1.1.2 United States : US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Breakdown, by Application
10.2.1.1.3 United States : US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Euroclone SpA

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 TissueGnostics GmbH

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Agilent Technologies Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Abnova Taiwan Corp

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 BioGenex Laboratories Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Leica Biosystems Nussloch GmbH

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 MetaSystems Probes GmbH

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Bio-View Ltd

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Thermo Fisher Scientific Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Applied Spectral Imaging

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 PerkinElmer Inc

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market